NASDAQ: ABCL
Abcellera Biologics Inc Stock Ownership - Who owns Abcellera Biologics?

Insider buying vs selling

Have Abcellera Biologics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Thermopylae Holdings Ltd10% Owner2025-03-11343,631$2.16
$742.24kBuy
John S. MontalbanoDirector2025-03-1025,000$2.30
$57.50kBuy
John S. MontalbanoDirector2025-03-0660,000$2.34
$140.58kBuy
Carl L. G. HansenChief Executive Officer2024-11-2556,125$2.70
$151.54kBuy
Carl L. G. HansenChief Executive Officer2024-09-2056,125$2.70
$151.54kBuy
Thermopylae Holdings Ltd10% Owner2024-08-29283,516$2.61
$739.98kBuy

1 of 1

ABCL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ABCL insiders and whales buy or sell their stock.

ABCL Shareholders

What type of owners hold Abcellera Biologics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Carl L. G. Hansen19.09%56,984,009$194.32MInsider
Thermopylae Holdings Ltd18.81%56,143,640$191.45MInsider
Baker Bros Advisors LP9.22%27,525,640$93.86MInstitution
Ubs Am A Distinct Business Unit Of Ubs Asset Management Americas LLC5.25%15,671,063$53.44MInstitution
John Hamer4.94%14,734,623$50.25MInsider
Capital World Investors4.48%13,361,096$45.56MInstitution
Baillie Gifford Co3.75%11,195,832$38.18MInstitution
Voya Investment Management LLC3.56%10,624,185$36.23MInstitution
Ubs Group Ag1.70%5,082,183$17.33MInstitution
Orbimed Advisors LLC1.40%4,180,768$14.26MInstitution

1 of 3

ABCL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABCL41.78%44.65%Net Buying
ELVN45.08%54.92%Net SellingNet Selling
VERV63.99%36.01%Net BuyingNet Selling
NVAX60.78%17.16%Net Selling
NTLA72.20%27.80%Net SellingNet Selling

Abcellera Biologics Stock Ownership FAQ

Who owns Abcellera Biologics?

Abcellera Biologics (NASDAQ: ABCL) is owned by 41.78% institutional shareholders, 44.65% Abcellera Biologics insiders, and 13.57% retail investors. Carl L. G. Hansen is the largest individual Abcellera Biologics shareholder, owning 56.98M shares representing 19.09% of the company. Carl L. G. Hansen's Abcellera Biologics shares are currently valued at $189.76M.

If you're new to stock investing, here's how to buy Abcellera Biologics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.